Log In
Sign Up
About Us
Magnolia Medical is an emerging growth commercial-stage medical device company that is developing solutions to challenges that have long plagued our healthcare system. Our Steripath® Initial Specimen Diversion Device® for blood collection and contamination prevention has created a new standard of care for prevention of false positive blood cultures, the gold standard diagnostic test for sepsis.
Steripath delivers significant clinical and cost savings benefits which have been extensively proven with large bodies of clinical data and peer-reviewed published studies. Based on this exceptional performance profile, we have an exclusive FDA-cleared indication for reducing blood culture contamination and uniquely provide a money-back Clinical Performance Guarantee for Steripath to our hospital customers.
With strong institutional investor backing, we offer highly committed and qualified candidates the opportunity to be a part of building a company dedicated to dramatically improving the accuracy of sepsis diagnostics to positively impact patient outcomes and hospital economics.
About the Role
The Financial, Planning & Analysis Manager will partner closely with MMT leadership across all aspects of financial analytics, reporting and system design/optimization (including areas of revenue, margins, department-level budgeting & reconciliation, cash flow analysis, etc.).
Responsibilities and Duties:
Support development of strategic plans and detailed budget needs (personnel/capital/specific initiatives/other) at both the individual department and well as top-line corporate level
Work with department heads to monitor and evaluate project spend and cash management, for example:
Clinical: implementation spending / cost management (both cash outflow, time burden) with an ROI evaluation
R&D: Project spend, and future cash outflows aligned with new project management process
Marketing: Support ROI evaluation of marketing campaigns and tradeshows
Support Revenue Operations as needed to analyze revenue and assist with evolution of efficient and effective reporting systems to enable predictive forecasting and results analysis
Working collaboratively with leadership, develop and implement capital efficiency-based metrics to help quantify ROIs on operating expense investments to drive growth
Partner with IT to enable effective tools for management to obtain financial insights on a timely basis
Help develop and evolve financial policies to align to our business processes
Support the annual and potential interim audits with our external auditors
Works with the other finance and IT personnel to develop and implement key controls around our financial statements and forecasting
Performs other duties as assigned.
Experience and Qualifications:
Bachelor’s degree in business, with a working knowledge of accounting and strong foundational experience in financial planning and analysis
At least 5 years’ experience working in a corporate finance organization. Practical experience with recurring revenue models is a strong plus
Excellent verbal and written communication skills, including active listening.
Enjoys building relationships with employees at all levels within the organization. Passion for supporting employees.
Flexible and adaptable to changing situations and needs.
Ability to manage time and resources effectively and productively, prioritize workload, and meet deadline.
Given access to sensitive information, strict adherence to confidentiality and discretion
Strong computer skills with proficiency in the use of Microsoft Office 365.
In particular, strong demonstrated financial modeling and presentation skills
Working experience within Salesforce and Microsoft Dynamics are a plus. General knowledge and passion to learn enterprise systems a must.
About Magnolia Medical Technologies, Inc.
Magnolia Medical Technologies develops, manufactures and markets innovative blood and bodily fluid collection devices to facilitate significant improvements in the accuracy, consistency and predictability of critical laboratory tests for patients in hospitals.
Dr. Richard Patton, the company’s co-founder, invented and patented the Initial Specimen Diversion Technique (ISDT™) and Initial Specimen Diversion Device (ISDD®) for blood culture collection and contamination prevention, and authored the seminal peer-reviewed publication on the efficacy of this technique the Journal of Clinical Microbiology in 2010.
The company’s flagship product, Steripath® Initial Specimen Diversion Device® for blood culture collection and contamination prevention, has been clinically proven in over 20 studies including 8 peer-reviewed publications in leading medical journals to virtually eliminate the preventable error of blood culture contamination and false positive results for the diagnosis of sepsis. Steripath delivers reductions in false positives of up to 92% with 12-month sustained contamination rates as low as 0.2% and an average cost savings of ~$1M a year for a typical US hospital.
Magnolia is establishing the new standard for blood culture integrity and sepsis testing accuracy and has effectively executed against its mission to change national blood culture collection guidelines and contamination benchmarks through CDC, CLSI and NQF.
The company has amassed an intellectual property portfolio including more than 125 issued method, apparatus and design patents with more than 50 additional patent applications pending.
Magnolia Medical is committed to the continued development and successful marketing of innovative products that will transform the way healthcare is practiced around the world. The company supports this effort by offering competitive compensation, incentive packages, benefits and career growth opportunities to the most qualified candidates in the marketplace.
Magnolia Medical Technologies, Inc. is an equal opportunity employer.
For more information, visit magnolia-medical.com
**As a condition of employment with Magnolia Medical Technologies, you are required to provide proof that you are fully vaccinated against COVID-19 or qualify for a reasonable accommodation.
